Literature DB >> 17034525

Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients.

E Weisshaar1, C Apfelbacher, G Jäger, E Zimmermann, T Bruckner, T L Diepgen, H Gollnick.   

Abstract

BACKGROUND: Pruritus is the most frequent and distressing symptom associated with dermatoses and various internal and neurological diseases.
OBJECTIVES: To investigate two different populations of patients with pruritus, one in Germany and one in Uganda, with a particular focus on clinical characteristics, aetiology and quality of life.
METHODS: We investigated by questionnaire 132 patients (59 men, 73 women, mean age 54.5 years) who were referred to the Department of Dermatology at the University Hospital of Magdeburg, Germany, with the diagnosis of pruritus as a leading symptom. The questionnaire was also applied in 84 patients who consulted the Dermatology Clinic at Mbarara, Uganda for pruritus. The questions referred to personal data and disease history of the individual, history and present occurrence of concomitant diseases, present and past therapy, quality, frequency and triggers of itching and scratching, other disorders and complaints, quality of life and impact on work and disability.
RESULTS: Seventy-five (57%) of the German patients had pruritus due to dermatoses, 47 patients (36%) had pruritus due to a systemic disease and in 10 patients (8%) pruritus was of unknown origin. Most had a history of pruritus of several months up to years. Pruritus associated with dermatoses mostly affected the whole body and was permanent with an undulatory character. Affective reactions such as aggression and depression occurred more frequently in dermatological patients compared with those with systemic pruritus. The former group felt that pruritus had a greater impact on their lives. Almost all Ugandan patients had pruritus due to dermatoses except for three patients with pruritus of unknown origin. Eczema and prurigo were the most frequently observed dermatoses in both German and Ugandan patients. Patients with pruritus in both populations showed an impaired quality of life. There was no pronounced difference between the populations with regard to feelings of depression and suicidal thoughts.
CONCLUSIONS: A great deal of helpful information in this complex group of patients can be obtained using this questionnaire. Pruritus has a major impact on quality of life and especially impairs those patients with pruritus associated with dermatoses and pruritus of unknown origin.

Entities:  

Mesh:

Year:  2006        PMID: 17034525     DOI: 10.1111/j.1365-2133.2006.07430.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  30 in total

1.  [Pruritus and psoriasis : an important but frequently underestimated relation].

Authors:  E Weisshaar
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

2.  [Pruritus, erythema and others. Dermatology of the ear].

Authors:  E Weisshaar; U Kallen; N Klintworth; J Zenk
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

3.  Pruritus in patients with solid tumors: an overlooked supportive care need.

Authors:  Jaxon J Vallely; Kathryn E Hudson; Susan C Locke; Steven P Wolf; Gregory P Samsa; Amy P Abernethy; Thomas W LeBlanc
Journal:  Support Care Cancer       Date:  2019-02-14       Impact factor: 3.603

4.  Intractable pruritus in neuromyelitis optica.

Authors:  Li Xiao; Wei Qiu; Zhengqi Lu; Rui Li; Xueqiang Hu
Journal:  Neurol Sci       Date:  2016-02-26       Impact factor: 3.307

5.  [Development of a German language questionnaire for assessing chronic pruritus (AGP-questionnaire): background and first results].

Authors:  E Weisshaar; S Ständer; U Gieler; U Matterne; U Darsow
Journal:  Hautarzt       Date:  2011-12       Impact factor: 0.751

6.  [Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)].

Authors:  S Ständer; C Blome; B Breil; P Bruland; U Darsow; M Dugas; A Evers; F Fritz; M Metz; N Q Phan; U Raap; A Reich; G Schneider; S Steinke; J Szepietowski; E Weisshaar; M Augustin
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

Review 7.  [Chronic pruritus: principals of diagnostics and therapy].

Authors:  S Ständer
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

8.  Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch.

Authors:  Tasuku Akiyama; Mitsutoshi Tominaga; Kenji Takamori; Mirela Iodi Carstens; E Carstens
Journal:  Pain       Date:  2013-09-13       Impact factor: 6.961

Review 9.  Oral H1 antihistamines as monotherapy for eczema.

Authors:  Christian J Apfelbacher; Esther J van Zuuren; Zbys Fedorowicz; Aldrin Jupiter; Uwe Matterne; Elke Weisshaar
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Roles for substance P and gastrin-releasing peptide as neurotransmitters released by primary afferent pruriceptors.

Authors:  Tasuku Akiyama; Mitsutoshi Tominaga; Auva Davoodi; Masaki Nagamine; Kevin Blansit; Alexander Horwitz; Mirela Iodi Carstens; E Carstens
Journal:  J Neurophysiol       Date:  2012-11-14       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.